Le Lézard
Classified in: Health
Subject: AWD

Carolyn Reinach Wolf is recognized by Continental Who's Who


LAKE SUCCESS, N.Y., July 16, 2018 /PRNewswire/ -- Carolyn Reinach Wolf is recognized by Continental Who's Who as a Pinnacle Lifetime Member in the field of Law in recognition of her role as an Executive Partner and Director of the Mental Health Law Practice at Abrams, Fensterman, Fensterman, Eisman, Formato, Ferrara, Wolf & Carone, LLP.

Serving the New York area for over eighteen years, Abrams, Fensterman, Fensterman, Eisman, Formato, Ferrara, Wolf & Carone, LLP is a full service law firm. "Committed to providing each client with quality counsel, innovative solutions and personalized service," the firm focuses on areas of mental health and health care law, representing families and individuals, major hospital systems and community hospitals, outpatient programs, mental health and health care professionals, higher educational institutions, and skilled nursing facilities.

With over thirty years of experience in the field of Mental Health Law, Carolyn Wolf is the only attorney in the country with a family-focused mental healthcare practice.  Having established herself as a distinguished professional in the industry, in her current capacity Wolf is currently an adjunct professor at Maurice A. Deane School of Law at Hofstra University, teaching both Law and Psychiatry. The depth and breadth of her experience has made her an awe-inspiring speaker and consultant to health care and mental health organizations as well as institutions of higher education, specifically university counseling centers and administrators, and professional associations throughout the country regarding mental health law issues. Wolf was admitted to practice in the New York State and Federal Courts as well as the U.S. Supreme Court.

Early in her career, Wolf attained her Juris Doctor degree from Hofstra University School of Law. In her previous years, Wolf attained her Master of Science in Health Services Administration from the Harvard School of Public Health and a Master of Business Administration degree in Management from the Hofstra University School of Business.  

In an effort to further enhance her professional development, Wolf maintains numerous affiliations with several organizations including the ASHRM, New York State Board of Directors; Nassau County Bar Association, Hospital and Health Law Committee; NCBA, Lawyers Assistance Program Committee; New York State Bar Association, Health Law Section; NYSBA, Health Law Section Subcommittee on Mental Health Law; National Center for Higher Education Risk Management, and National Behavioral Intervention Team Association president 2016-2017.

A prominent scholar, Wolf co-authored several publications including The Risk Management Quarterly Journal article, The Increased Threat of Hospital Liability and After Munsey v. Delia in August 2017.

In recognition of her professional accolades, Wolf has been selected to the New York Super Lawyers list since 2013.

For more information, please visit https://www.abramslaw.com

Contact: Katherine Green, 516-825-5634, [email protected]

SOURCE Continental Who's Who


These press releases may also interest you

at 10:54
Pierre Fabre Laboratories announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of OBGEMSAtm (vibegron under the international...

at 10:49
Sustain Exchange LLC is proud to announce a partnership with HearMe, a leading behavioral health peer support platform focused on ensuring healthy lives and promoting well-being. As part of this innovative partnership, SustainAble Exchange will...

at 10:45
C?N Diagnostics, LLC ("C2N"), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, today announced a partnership agreement with Mediford Corporation, a PHC Holdings Corporation (TSE 6523) Group Company and premier...

at 10:35
BeiGene, Ltd. , a global oncology company, released its 2023 Responsible Business & Sustainability Report highlighting the Company's strategy, the progress it has made towards existing goals, and how it intends to achieve its bold new targets. This...

at 10:30
Invensify, Inc., Santa Clara, California, has introduced a power efficient, temperature-controlled shipping container designed to maintain stable storage temperatures for high-value pharmaceuticals before and during transport to last-mile cold chain...

at 10:30
Oligonucleotide Synthesis Market in terms of revenue was estimated to be worth $8.8 billion in 2024 and is poised to reach $19.7 billion by 2029, growing at a CAGR of 17.5% from 2024 to 2029 according to a new report by MarketsandMarketstm. One of...



News published on and distributed by: